Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Prucalopride in Severe Chronic Constipation
NCT00576511Phase 2Completed
- Sponsor
- Movetis
- Start
- Dec 1994
- Primary completion
- Feb 1996
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in chronic constipation comparing Prucalopride with Placebo (2 arms). Primary endpoint: Constipation severity (VAS) at 4 weeks. Started Dec 1994; status: completed.
02
Drugs
prucalopride
03
Conditions
chronic constipation
Beyond the preview
Go deeper on NCT00576511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00576511.